Eprimat SR Capsule contains Eperisone 150 mg, a centrally acting muscle relaxant indicated for the management of muscle spasticity and associated pain. Eperisone exerts its pharmacological effect by inhibiting spinal reflexes and improving blood flow to skeletal muscles, thereby reducing muscle stiffness and enhancing motor function. It is commonly prescribed for conditions such as cervical spondylosis, lumbar spondylosis, spastic paralysis, and other musculoskeletal disorders characterized by increased muscle tone and pain. The sustained-release formulation of Eprimat SR ensures a prolonged therapeutic effect, allowing for twice-daily dosing and improved patient compliance. Eperisone is well-tolerated, with a low incidence of adverse effects; however, patients may experience mild side effects such as dizziness, headache, or gastrointestinal discomfort. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision. Eprimat SR Capsule should not be combined with alcohol or other central nervous system depressants due to the risk of enhanced sedation. Overall, Eprimat SR Capsule is an effective option for managing muscle spasticity, improving patient mobility, and reducing pain associated with neuromuscular conditions.